Wearable Technology for Non-Invasive Glucose Monitoring
US-2017164878-A1 · Jun 15, 2017 · US
US11766197B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11766197-B2 |
| Application number | US-202016780552-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 3, 2020 |
| Priority date | Feb 12, 2017 |
| Publication date | Sep 26, 2023 |
| Grant date | Sep 26, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed in an embodiment is an operating method of portable apparatus for noninvasively measuring blood glucose levels. The method includes: (a) measuring a first signal value according to ambient environmental light when an LED for measuring signals which emits light with wavelengths to be absorbed into or scattered by glucose is switched off; (b) measuring a second signal value according to light which is scattered by or transmitted through subject tissue and enters a photodetecting unit when the LED for measuring signals is switched on; (c) calculating a glucose concentration measurement of a subject by using the first signal value and the second signal value; and (d) adjusting the quantity of the light radiated from the LED for measuring signals by feeding the difference between the glucose concentration measurement and a pre-established first reference value back to the driving current for the LED for measuring signals.
Opening claim text (preview).
What is claimed is: 1. A method of operating a portable apparatus for noninvasively measuring blood glucose levels, comprising: (a) measuring a first signal value by using a photodiode detector when a light source which emits light with a wavelength range to be absorbed into or scattered by glucose is switched off; (b) measuring a second signal value according to light which is scattered by or transmitted through a tissue of a subject and enters the photodiode detector when the light source which emits the light with the wavelength range is switched on; (c) calculating a glucose concentration measurement of the subject by using the first signal value and the second signal value; and (d) adjusting an intensity of the light emitted from the light source based on a difference between the glucose concentration measurement and a first reference value. 2. The method of claim 1 , further comprising: (e) the steps from (b) through (d) are repeatedly performed until the glucose concentration measurement becomes equal to the first reference value. 3. The method of claim 1 , wherein, in the step (d), a driving current for the light source is reduced when a result of subtracting the first reference value from the glucose concentration measurement is positive while the driving current for the light source is increased when the result of subtracting the first reference value from the glucose concentration measurement is negative. 4. The method of claim 1 , wherein the step (c) comprises: (c-1) calculating the glucose concentration measurement by correcting the second signal value by subtracting the first signal value from the second signal value; and (c-2) producing a blood glucose measuring result of the subject by comparing the glucose concentration measurement with a blood glucose level table corresponding to each glucose concentration. 5. The method of claim 1 , further comprising: (f) measuring a third signal value according to light which is scattered by or transmitted through the tissue of the subject and enters the photodiode detector when a reference light source which emits light with a second wavelength range which are neither absorbed in nor scattered by the glucose is switched on; (g) calculating a compensating value to compensate for a change in an amount of scattering or transmission according to skin characteristics and body temperature of the subject based on a difference between a reference measurement produced by a difference between the first signal value and the third signal value, and a second reference value established with reference to a standard subject; and (h) adjusting a driving current for the light source based on the compensating value, prior to the step (b), wherein the wavelength range is 800 to 1000 nm and the second wavelength range is 600 to 800 nm. 6. The method of claim 5 , wherein the step (b) comprises: (b-1) measuring the second signal value when the light source driven with the driving current is switched on; and (b-2) measuring again the first signal value when the light source is switched off. 7. The method of claim 5 , wherein the step (g) comprises determining the compensating value by comparing the difference between the reference measurement and the second reference value with a table with regard to glucose detection changes according to previously stored skin colors. 8. The method of claim 5 , wherein the step (h) comprises reducing the driving current for the light source when the compensating value is positive, and increasing the driving current for the light source when the compensating value is negative. 9. The method of claim 1 , further comprising (i) removing noise out of and correcting the first signal value and the second signal value based on an autofocusing algorithm. 10. A portable apparatus for noninvasively measuring blood glucose levels, comprising: a light source which emits light with a wavelength range absorbed into or scattered by glucose; a photodiode detector which includes at least one light receiving element, for converting light received by the light receiving element into an electrical signal; and a processor which is connected to the photodiode detector and configured to (a) collect a first signal value from the photodiode detector when the light source is switched off, (b) collect a second signal value detected according to light which is scattered by or transmitted through a tissue of a subject and enters the photodiode detector when the light source is switched on, (c) calculate a glucose concentration measurement of the subject by using the first signal value and the second signal value, and (d) adjust an intensity of the light emitted from the light source based on a difference between the glucose concentration measurement and a first reference value. 11. The portable apparatus of claim 10 , wherein the processor is configured to repeatedly perform (b) through (d) until the glucose concentration measurement becomes equal to the first reference value. 12. The portable apparatus of claim 10 , wherein the processor is configured to reduce a driving current for the light source when a result of subtracting the first reference value from the glucose concentration measurement is positive while the driving current for the light source is increased when the result of subtracting the first reference value from the glucose concentration measurement is negative. 13. The portable apparatus of claim 10 , wherein the processor is configured to produce the glucose concentration measurement by correcting the second signal value by subtracting the first signal value from the second signal value and produce a blood glucose measuring result of the subject by comparing the glucose concentration measurement with a blood glucose level table corresponding to each glucose concentration. 14. The portable apparatus of claim 10 , further comprising a reference light source which emits light with a second wavelength range which are neither absorbed in nor scattered by the glucose, wherein the processor is configured to collect a third signal value detected according to light which is scattered by or transmitted through the tissue of the subject and enters the photodiode detector by switching the reference light source on when the light source is switched off, calculate a compensating value to compensate for a change in an amount of scattering or transmission according to skin characteristics and body temperature of the subject based on a difference between a reference measurement produced by a difference between the first signal value and the third signal value, and the second reference value established with reference to a standard subject, and adjust a driving current for the light source based on the compensating value, wherein the wavelength range is 800 to 1000 nm and the second wavelength range is 600 to 800 nm. 15. The portable apparatus of claim 14 , wherein the processor is configured to measure the second signal value by using the light source driven with the adjusted driving current after switching the reference light source off, and measure the first signal value again by switching the light source off. 16. The portable apparatus of claim 14 , wherein the processor is configured to determine the compensating value by comparing the difference between the reference measurement and the second reference value with a table with regard to glucose detection changes according to previously stored skin colors. 17. The portable apparatus of claim 14 , wherein the processor is configured to reduce the driving current for th
for interstitial fluid · CPC title
using enzyme electrodes, e.g. with immobilised oxidase · CPC title
using light, e.g. diagnosis by transillumination, diascopy, fluorescence (photoacoustic A61B5/0093; optical measurement of heart rate A61B5/02416; optical measurement of blood flow A61B5/0261; optical measurement of analytes A61B5/1455) · CPC title
for oral or dental tissue · CPC title
by measuring fluorescence emission · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.